Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Putra MalaysiafiledCriticalUniv Putra Malaysia
Priority to MYPI2012005700ApriorityCriticalpatent/MY168662A/en
Publication of MY168662ApublicationCriticalpatent/MY168662A/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Micro-Organisms Or Cultivation Processes Thereof
(AREA)
Abstract
The present invention relates to an attenuated bacterium for use as a medicament which stimulates protective immunity against normal growth of pathogenic Pasteurella bacteria. the invention also relates to immunogenic preparations including vaccines against disease caused by infection by a virulent Pasteurella strain and tools for the generation of immunological and diagnostic reagents. Further, the present invention relates to live attenuated recombinant bacteria carrying a gene and vaccines based thereon that can be administered to animals, particularly ruminants to provide protective immunity against challenge by Pasteurella bacteria. Also disclosed are the bacterium polypeptide and includes polypeptide sequences, gene sequences encoding the polypeptide, vectors to contain the said sequences, and host cells transformed with the said vectors which include nucleotide sequences of the polypeptide sequences. Figure 2
MYPI2012005700A2007-02-132007-02-13Attenuated bacteria for use in a vaccine
MY168662A
(en)
Herpesvirus, DNA sequence, vector, cell, virus, method for producing infectious particles, infectious particles, vaccine, use of herpesvirus or DNA sequence or vector or infectious particles, and method for preventive and / or treatment. treatment of a disease.